AstraZeneca | Zee News

Advertisement

NewsAstraZeneca

AstraZeneca News

08 May 2024

DNA: Astrazeneca withdraws Covid vaccine

08 May 2024

Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally

According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations.

Thrombosis with Thrombocytopenia Syndrome

30 Apr 2024

AstraZeneca's Covishield Vaccine Can Lead To Blood Clots: Know All About TTS

TTS is thrombosis with thrombocytopenia syndrome, which is a clot in blood vessels of the brain or elsewhere, along with a low platelet count TTS has emerged as a rare but significant concern associated with the AstraZeneca Covid-19 vaccine A doctor, however, emphasised that these findings don't change the fact that the vaccines were essential to fight COVID-19

02 Jun 2022

Monkeypox cases due to the side effect of Covid-19 vaccine? Answer here

Monkeypox outbreak: Social media posts claiming the chimpanzee adenovirus vector used in AstraZeneca's Covid vaccine, causes Monkeypox have surfaces, PTI reported.

23 Dec 2021

AstraZeneca boosters offer significant protection against Omicron: Researchers

Novavax Inc also said that early data showed its vaccine generated an immune response against Omicron First identified last month in Southern Africa and Hong Kong, Omicron has rapidly spread across the globe AstraZeneca's Covishield is largely used in India

09 Dec 2021

US clears AstraZeneca antibody for treating cases of COVID-19 infections

The AstraZeneca antibody-drug cleared by the US Food and Drug Administration on Wednesday is different. It's the first authorised for long-term prevention against COVID-19 infection, rather than short-term treatment.

World Heart Day

29 Sep 2021

World Heart Day: AstraZeneca to use new vaccine technology to heart disease

AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions Imperial scientists had aimed to use the technology to design a COVID-19 jab

22 Sep 2021

Covishield now an approved vaccine in UK - what it means for India

Foreign Secretary Harsh Shringla had earlier said that non-recognition of Covishield COVID-19 vaccine is a discriminating policy.

25 Aug 2021

Thailand develops robotic system to draw out vaccine doses efficiently

The system can draw 12 doses of the AstraZeneca vaccine in four minutes The machine only works on AstraZeneca multi-dose vials currently

19 Aug 2021

'Pfizer, AstraZeneca COVID-19 vaccines less effective against Delta variant'

Oxford researchers have claimed that Pfizer, AstraZeneca COVID-19 vaccines are less effective against Delta variant They, however, said that these vaccines still offer good protection against new infections

12 Aug 2021

Rare blood clot from AstraZeneca's COVID-19 vaccine poses high risk of death

A study has found a syndrome linked with AstraZeneca vaccine that has high fatality risk The occurrence of blood clot syndrome is very low The syndrome affects even the young and healthy

27 Jul 2021

AstraZeneca, Pfizer vaccine antibody levels may decline after 2-3 months:Study

The findings based on data from over 600 people aged 18 and above were consistent across all groups of people regardless of age, chronic illnesses or sex, according to the researchers. The UCL Virus Watch study also found that antibody levels are substantially higher following two doses of the Pfizer vaccine than after two shots of the AstraZeneca preventive. The authors highlight that although the clinical implications of waning antibody levels are not yet clear, some decline was expected

coronavirus vaccine

03 Jul 2021

As India gears up for Moderna, list of other vaccine options available

Moderna will become the fourth vaccine to be available for use in India The Centre plans to provide the Moderna doses directly to states Pfizer will supply one billion doses to India within this year

02 Jul 2021

British PM Boris Johnson says Covishield shot should be accepted in schemes

About 5 million people in Britain are thought to have had the vaccine made by Serum Institute in India India saw a single-day rise of 46,617 new coronavirus infections The death toll due to COVID-19 rose to 4,00,312 with 853 daily fatalities

28 Jun 2021

AstraZeneca tests COVID booster shots against Beta-variant

AstraZeneca tests booster dose called AZD2816 for protection against the 'beta variant' of the COVID-19 virus Beta variant originated in South Africa

28 Jun 2021

AstraZeneca begins trials for modified booster vaccine against Beta variant

The current vaccines available against COVID-19 are believed to be less effective against the Beta variant. This new booster COVID-19 vaccine, developed by AstraZeneca, is known as AZD2816.

COVID-19 vaccine

24 Jun 2021

Single jab of Pfizer, AstraZeneca offers 60 per cent protection: Lancet study

The research investigated SARS-CoV-2 transmission, infection outcomes, and immunity in residents and staff in long-term care facilities in England for adults aged 65 years and older since June 2020. This study was completed before the emergence of the Delta variant of SARS-CoV-2 now dominating in the UK. However, even beyond four weeks, a single vaccine dose does not eliminate infection risk.

COVID-19 variant

22 Jun 2021

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80% effective in preventing infection from B1.617.2 variant of COVID-19 The UK findings are said to be based on data from PHE and have also revealed that the two doses provide 87% protection from the B.117 variant

19 Jun 2021

When to take second Covishield vaccine dose? Here’s what AstraZeneca says

Professor Andrew Pollard said the immunization policy in Britain and India should not be compared because of the different circumstances in the two countries. “An immunization policy that aims to vaccinate the largest number of people in the quickest possible time with at least one dose makes sense in the present circumstances in India,” Pollard said.

10 Jun 2021

AstraZeneca COVID vaccine linked with small risk of low blood platelets: Study

AstraZeneca COVID vaccine may be linked with a small risk of low blood platelets, says a new study The study was conducted by researchers at the University of Edinburgh in the UK

Loading...

NEWS ON ONE CLICK